Ardian Inc., a Palo Alto, Calif.-based developer of a medical device to treat congestive heart failure, has secured $30 million of a $60 million venture round, according to a regulatory filing. Listed shareholders include return backers Advanced Technology Ventures, Morgenthaler Ventures and St. Paul Venture Capital. It had previously raised over $18 million.
